68 research outputs found
The effect of pharmacological inhibition of Serine Proteases on neuronal networks in vitro
This work was supported by the European Union\u2019s Framework Programme for Research and Innovation (under the H2020 ETN grant n. 642881 to Stefanie Dedeurwaerdere, Pieter Van Der Veken, and Koen Augustyns; under the Specific Grant Agreement n. 785907 - Human Brain Project to Michele Giugliano; and under FP7 grants n. 286403 and n. 284801 to Michele Giugliano), the European Union\u2019s Research Area Networks (NEURON II to Stefanie Dedeurwaerdere), the Flemish Research Foundation (grants n. G0F1517N and n. K201619N to Michele Giugliano), the University of Antwerp (grant n. BOF-DOCPRO-2016 to Michele Giugliano), and the Scuola Internazionale Superiore di Studi Avanzati (\u2018\u2018Collaborazione di Eccellenza 2018\u2019\u2019 to Michele Giugliano). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript
Development of irreversible diphenyl phosphonate inhibitors for urokinase plasminogen activator
Solid and solution phase syntheses of the 2-cyanopyrrolidide DPP-IV inhibitor NVP-DPP728
DPP-IV inhibitors have been suggested as potential new treatments for type-II diabetes and 2-cyanopyrrolidides have been reported as potent DPP-IV inhibitors. Alternative synthetic approaches to one such compound, NVP-DPP728, are investigated here. One strategy is based in solution phase and is amenable to scale-up. The other is based on solid phase and is appropriate for the rapid analoging of the structural series
Novel selective glucocorticoid receptor agonists (SEGRAs) with a covalent warhead for long-lasting inhibition
Repositioning the Substrate Activity Screening (SAS) approach as a fragment-based method for identification of weak binders
Disubstituted triazine dimers for treatment and/or prevention of infectious diseases : WO2013068551
- …